In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Reliant Technologies

This article was originally published in The Gray Sheet

Executive Summary

Mountain View, Calif., aesthetics device maker announces 510(k) clearance July 2 of its Fraxel re:pair laser with Fractional Deep Dermal Ablation for ablation, coagulation and skin resurfacing based on data from an ongoing, 200-patient, 10-site clinical trial. In the first phase of the trial, over 75% of patients treated with Fraxel re:pair showed improved appearance of rhytids, vascular dyschromia, pigmentation and skin laxity. Two later phases are evaluating the device for scar treatment. Reliant's other lasers on the market include Fraxel re:store for skin resurfacing and scar and wrinkle treatment, and Fraxel re:fine for gentle skin rejuvenation...

You may also be interested in...

Reliant Technologies IPO Will Support 2008 Launch Of Skin Repair Laser

Aesthetic laser manufacturer Reliant Technologies will launch its Fraxel Re:pair system for treatment of severe skin conditions in the first quarter of 2008, supported by the proceeds of a proposed initial public stock offering of up to $95 million

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts